Biotech Kyverna surges 36 percent in US debut
Bringing Taiwan to the World and the World to Taiwan
Source: taipeitimes.com
Page 3 - Peter Maag News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Peter Maag. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Peter Maag Today - Breaking & Trending Today
Kyverna Therapeutics Granted FDA Fast Track Designation for KYV-101 in the Treatment of Patients With Refractory Progressive Multiple Sclerosis
/PRNewswire/ -- Kyverna Therapeutics, Inc. (Kyverna), a patient-centered clinical-stage biopharmaceutical company focused on developing cell therapies for...
Source: prnewswire.com
FDA Grants Fast Track Status to Anti-CD19 CAR T-Cell Therapy for MS
The FDA has granted Fast Track designation to KYV-101 for the treatment of refractory, progressive multiple sclerosis.
Source: empr.com
KYV-101 Multiple Sclerosis Treatment Gets FDA Clearance - Physical Therapy Products
A study will seek to answer whether CAR T-cell therapy using KYV-101 offers a new treatment option for patients living with MS.
Source: ptproductsonline.com